392 related articles for article (PubMed ID: 8261874)
1. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
[TBL] [Abstract][Full Text] [Related]
6. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
[TBL] [Abstract][Full Text] [Related]
7. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
Li S; Zhang C; Xu E
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood testing and the incidence of colorectal cancer.
Singer RB
J Insur Med; 2002; 34(2):89-91. PubMed ID: 15305783
[TBL] [Abstract][Full Text] [Related]
11. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
12. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
13. [Mass screening for colorectal cancer--issues and future prospects].
Kobayashi S
Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
15. Results of screening for colorectal cancer.
Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E
Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
[TBL] [Abstract][Full Text] [Related]
16. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer screening. Sigmoidoscopy or colonoscopy.
Khullar SK; DiSario JA
Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
[TBL] [Abstract][Full Text] [Related]
19. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
[TBL] [Abstract][Full Text] [Related]
20. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
Adamsen S; Kronborg O
Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
